These results suggest that IL-17A and TNF-α may inhibit cognitive and motor recovery, while VEGF-A may alleviate brain injury and accelerate brain function recovery at an early stage following ischemic stroke, which is in line with the results from previous studies (Rreed et al., 2020; Zuo et al., 2022). The gene discussed is TNF; the disease is ischemic stroke.